Antitumor activity of sustained N-Myc reduction in rhabdomyosarcomas and transcriptional block by antigene therapy
Antitumor activity of sustained N-Myc reduction in rhabdomyosarcomas and transcriptional block by antigene therapy
PURPOSE: Rhabdomyosarcomas are a major cause of cancer death in children, described with MYCN amplification and, in the alveolar subtype, transcription driven by the PAX3-FOXO1 fusion protein. Our aim was to determine the prevalence of N-Myc protein expression and the potential therapeutic effects of reducing expression in rhabdomyosarcomas, including use of an antigene strategy that inhibits transcription.
EXPERIMENTAL DESIGN: Protein expression was assessed by immunohistochemistry. MYCN expression was reduced in representative cell lines by RNA interference and an antigene peptide nucleic acid (PNA) oligonucleotide conjugated to a nuclear localization signal peptide. Associated gene expression changes, cell viability, and apoptosis were analyzed in vitro. As a paradigm for antigene therapy, the effects of systemic treatment of mice with rhabdomyosarcoma cell line xenografts were determined.
RESULTS: High N-Myc levels were significantly associated with genomic amplification, presence of the PAX3/7-FOXO1 fusion genes, and proliferative capacity. Sustained reduction of N-Myc levels in all rhabdomyosarcoma cell lines that express the protein decreased cell proliferation and increased apoptosis. Positive feedback was shown to regulate PAX3-FOXO1 and N-Myc levels in the alveolar subtype that critically decrease PAX3-FOXO1 levels on reducing N-Myc. Pharmacologic systemic administration of the antigene PNA can eliminate alveolar rhabdomyosarcoma xenografts in mice, without relapse or toxicity.
CONCLUSION: N-Myc, with its restricted expression in non-fetal tissues, is a therapeutic target to treat rhabdomyosarcomas, and blocking gene transcription using antigene oligonucleotide strategies has therapeutic potential in the treatment of cancer and other diseases that has not been previously realized in vivo.
Animals, Apoptosis, Blotting, Western, Cell Line, Tumor, Electrophoretic Mobility Shift Assay, Gene Dosage, Genes, myc, Genetic Therapy, Humans, Immunohistochemistry, In Situ Nick-End Labeling, Mice, Mice, Nude, N-Myc Proto-Oncogene Protein, Nuclear Proteins, Oncogene Proteins, Oncogene Proteins, Fusion, Paired Box Transcription Factors, Peptide Nucleic Acids, Proto-Oncogene Proteins c-myc, Real-Time Polymerase Chain Reaction, Reverse Transcriptase Polymerase Chain Reaction, Rhabdomyosarcoma, Transcription, Genetic, Xenograft Model Antitumor Assays, Journal Article, Research Support, Non-U.S. Gov't
796-807
Tonelli, Roberto
830985c1-1bcf-48ca-8621-8dfae21b07c3
McIntyre, Alan
9a29f201-5984-4828-bc98-b7a8406dd75c
Camerin, Consuelo
e0824968-76e7-41fd-8760-09c029174f40
Walters, Zoë S.
e1ccd35d-63a9-4951-a5da-59122193740d
Di Leo, Korinne
331f26dc-0b16-47fd-8751-8aa3ff388472
Selfe, Joanna
3853ed08-1f71-4983-a49f-3dba1625383f
Purgato, Stefania
ac1c0db6-e814-48a7-a90a-2fa590f7f327
Missiaglia, Edoardo
5c63d29e-3aad-4bc0-82ec-aa7d18896207
Tortori, Andrea
670e0126-3a55-469a-bf1b-c650b2a4352c
Renshaw, Jane
adf0a804-3208-4f7b-b990-1bbabbb8d427
Astolfi, Annalisa
7c6bf0d0-1b52-4f8d-a897-8eb572b14e15
Taylor, Kathryn R.
1f571efa-5b2e-4b6f-ac30-e0209467eab7
Serravalle, Salvatore
3395bd09-f359-48fc-9ed4-e51511b1eaf9
Nanni, Cristina
cfc1f43f-bd1c-4ecf-9a88-13cdcdcd4ee8
Valentijn, Linda J
333b2eea-d136-4d95-9408-74f06c175f6d
Faccini, Andrea
06548993-c82f-4124-bf87-89cdb3b64055
Leuschner, Ivo
ec38e00f-809b-44b7-9674-3bf335d234a7
Formica, Serena
33aa75e2-abe5-45a5-a3dd-320cd9afc075
Reis-Filho, Jorge S.
62a35a8f-49c4-4714-bf88-fed1bb2aae05
Ambrosini, Valentina
0637d78e-3c09-463d-acb0-751c2af338c8
Thway, Khin
5ca9bf5a-18e3-447d-b578-631fa8c130f7
Franzoni, Monica
f92b04a7-2b34-4c20-bda2-0e3680f6239b
Summersgill, Brenda
cd1829c5-f735-46c1-a1c6-e57dd507456e
Marchelli, Rosangela
79a26652-b4b8-43d2-94da-90ae43225116
Hrelia, Patrizia
7e3c9a88-3e98-4b32-b77f-60f94b45b41b
Cantelli-Forti, Giorgio
6f874cac-8561-406b-822d-e29313ce980e
Fanti, Stefano
4abfa53e-699c-4ae3-a21d-345453f52714
Corradini, Roberto
c0241238-dfb9-4b3d-89d8-c2ab8062c9c3
Pession, Andrea
c4d33ace-0317-412b-8bdf-71a4edc0514e
Shipley, Janet
c4bd3760-d826-42ba-8321-ce78582034ac
1 February 2012
Tonelli, Roberto
830985c1-1bcf-48ca-8621-8dfae21b07c3
McIntyre, Alan
9a29f201-5984-4828-bc98-b7a8406dd75c
Camerin, Consuelo
e0824968-76e7-41fd-8760-09c029174f40
Walters, Zoë S.
e1ccd35d-63a9-4951-a5da-59122193740d
Di Leo, Korinne
331f26dc-0b16-47fd-8751-8aa3ff388472
Selfe, Joanna
3853ed08-1f71-4983-a49f-3dba1625383f
Purgato, Stefania
ac1c0db6-e814-48a7-a90a-2fa590f7f327
Missiaglia, Edoardo
5c63d29e-3aad-4bc0-82ec-aa7d18896207
Tortori, Andrea
670e0126-3a55-469a-bf1b-c650b2a4352c
Renshaw, Jane
adf0a804-3208-4f7b-b990-1bbabbb8d427
Astolfi, Annalisa
7c6bf0d0-1b52-4f8d-a897-8eb572b14e15
Taylor, Kathryn R.
1f571efa-5b2e-4b6f-ac30-e0209467eab7
Serravalle, Salvatore
3395bd09-f359-48fc-9ed4-e51511b1eaf9
Nanni, Cristina
cfc1f43f-bd1c-4ecf-9a88-13cdcdcd4ee8
Valentijn, Linda J
333b2eea-d136-4d95-9408-74f06c175f6d
Faccini, Andrea
06548993-c82f-4124-bf87-89cdb3b64055
Leuschner, Ivo
ec38e00f-809b-44b7-9674-3bf335d234a7
Formica, Serena
33aa75e2-abe5-45a5-a3dd-320cd9afc075
Reis-Filho, Jorge S.
62a35a8f-49c4-4714-bf88-fed1bb2aae05
Ambrosini, Valentina
0637d78e-3c09-463d-acb0-751c2af338c8
Thway, Khin
5ca9bf5a-18e3-447d-b578-631fa8c130f7
Franzoni, Monica
f92b04a7-2b34-4c20-bda2-0e3680f6239b
Summersgill, Brenda
cd1829c5-f735-46c1-a1c6-e57dd507456e
Marchelli, Rosangela
79a26652-b4b8-43d2-94da-90ae43225116
Hrelia, Patrizia
7e3c9a88-3e98-4b32-b77f-60f94b45b41b
Cantelli-Forti, Giorgio
6f874cac-8561-406b-822d-e29313ce980e
Fanti, Stefano
4abfa53e-699c-4ae3-a21d-345453f52714
Corradini, Roberto
c0241238-dfb9-4b3d-89d8-c2ab8062c9c3
Pession, Andrea
c4d33ace-0317-412b-8bdf-71a4edc0514e
Shipley, Janet
c4bd3760-d826-42ba-8321-ce78582034ac